Evidence map›Paper›PMID 39814884›Full record

ArticleNature2025

Targeting FOXM1 condensates reduces breast tumour growth and metastasis.

Feng Xie, Xiaoxue Zhou, Yu Ran, Ran Li, Jing Zou, Shiyun Wan, Peng Su, Xuli Meng, Haiyan Yan, Huasong Lu and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Review
  3. Aberrant phase separation from a rare ABI3 mutation drives microglial dysfunction and Alzheimer's risk.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Feng Xie *The First Affiliated Hospital, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China. xiefeng@suda.edu.cn.ORCID 0000-0003-3785-7609
Xiaoxue Zhou *School of Medicine, Hangzhou City University, Hangzhou, China.
Yu RanLife Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
Ran LiSchool of Medicine, Hangzhou City University, Hangzhou, China.
Jing ZouLife Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
Shiyun WanThe First Affiliated Hospital, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China.
Peng SuKey Laboratory for Diagnosis and Treatment of Upper Limb Edema and Stasis of Breast Cancer, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, China.
Xuli MengKey Laboratory for Diagnosis and Treatment of Upper Limb Edema and Stasis of Breast Cancer, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, China.
Haiyan YanSchool of Medicine, Hangzhou City University, Hangzhou, China.
Huasong LuLife Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.ORCID 0000-0003-0875-5531
Heng RuLife Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
Hai HuZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
Zhengwei MaoMOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China. zwmao@zju.edu.cn.ORCID 0000-0001-7990-2856
Bing YangLife Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China. bingyang@zju.edu.cn.ORCID 0000-0001-6739-2932
Fangfang ZhouThe First Affiliated Hospital, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China. zhoufangfang@suda.edu.cn.ORCID 0000-0003-1870-7584
Long ZhangFrontiers Medical Center, Tianfu Jincheng Laboratory, Chengdu, China. l_zhang@zju.edu.cn.ORCID 0000-0001-8139-0474

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying phase-separated structures remains challenging, and effective intervention methods are currently lacking

Indexed as

Breast NeoplasmsForkhead Box Protein M1Neoplasm MetastasisAMP-Activated Protein KinasesAnimalsCell Line, TumorCell ProliferationChromatinFemaleGene Expression Regulation, NeoplasticHumansImmunotherapyMicePeptidesPhosphorylationTranscription, GeneticAMP-Activated Protein KinasesChromatinForkhead Box Protein M1FOXM1 protein, humanPeptides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.